hicar-t
Generic: anti-CD19 CAR-T
hicar-t: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Orgenesis Inc. (ORGS) | Preclinical |
Get deeper analysis on hicar-t
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis